vimarsana.com

Page 31 - ஒன்றுபட்டது கிஂக்டம் ஸ்விட்ச் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Coronavirus: EU and AstraZeneca seek to resolve vaccine supply crisis

BBC News Published media captionStella Kyriakides: AstraZeneca needs to deliver on its commitments The EU and the UK-based Covid vaccine maker AstraZeneca have vowed to work together to resolve a bitter row over supply shortages to the bloc. AstraZeneca had agreed to deliver millions of doses in January-March but then said significantly fewer jabs would arrive on time. It blamed production problems at European plants. The EU is demanding the firm divert jabs from the UK. The UK government has said there will be no interruption to UK supply. Cabinet Minister Michael Gove said it was critical to make sure that the schedule that has been agreed and on which our vaccine has been based goes ahead .

German Vaccine Commission Only Recommends AstraZeneca Jabs for Under-65s

German Vaccine Commission Only Recommends AstraZeneca Jabs for Under-65s © AP Photo / Siphiwe Sibeko Subscribe Sputnik International https://sputniknews.com/europe/202101281081906803-German-vaccine-commission-only-recommends-astrazeneca-jabs-for-under-65s/ The committee pointed in its recommendations to a lack of scientific data, which prevents it from advising the use of the British-Swedish flagman coronavirus inoculation in older age groups. AstraZeneca s coronavirus vaccine should only be offered to people who are under 65, Germany s vaccine committee stated in an update to its recommendations, citing a lack of sufficient data to recommend use in older age groups. There are currently insufficient data available to assess the vaccine efficacy from 65 years of age, the committee said in the resolution recently released by the German health ministry.

Thailand s vaccination programme will not be complete until the end of 2022 says Health Minister Anutin

Thailand’s vaccination programme will not be complete until the end of 2022 says Health Minister Anutin A Super Poll survey in recent days shows the public firmly behind the government and in stout agreement with the legal action being taken against the Progressive Movement leader who is still defending his controversial claims that the country’s vaccination plans are flawed and too reliant on the AstraZeneca vaccine including its deal here with a firm owned by the Crown Property Bureau, a claim which last week produced a forceful and angry response from officials starting with the Prime Minister. As the controversy over Thailand’s vaccination strategy against Covid-19 rages with Lèse-majesté proceedings being taken against Progressive Movement leader Thanathorn Juangroongruangkit, the Minister of Public Health Anutin Charnvirakul has suggested that the programme will not be complete until the end of 2022.

EU-UK Vaccine Row: Britain Has Been Lucky to Develop Its Own COVID Jab, Academics Say

EU-UK Vaccine Row: Britain Has Been Lucky to Develop Its Own COVID Jab, Academics Say © REUTERS / Stefan Rousseau Subscribe Sputnik International https://sputniknews.com/uk/202101281081898516-eu-uk-vaccine-row-britain-has-been-lucky-to-develop-its-own-covid-jab-academics-say/ The UK and the EU have crossed swords over coronavirus vaccine supplies as Brussels warned it could restrict exports of the Belgian-made Pfizer jab to Britain, prompting Health Secretary Matt Hancock to accuse the union of “protectionism”. British observers have weighed up whether the bloc s restrictions may hurt Britain s inoculation plans. The EU-British vaccine row came amid growing frustration with temporary reductions in the shipment of Pfizer’s COVID-19 shots within the bloc as the firm is up-scaling its manufacturing facilities in Belgium. To add to the controversy, the UK-Swedish pharma company AstraZeneca has signalled that it will cut deliveries

Coronavirus: Germany facing 10 tough weeks of vaccine shortages

Coronavirus: Germany set to limit AstraZeneca jab to under-65s Published image captionGermany s government has been criticised for its vaccine programme s slow start Germany s vaccine committee has said AstraZeneca s Covid jab should only be given to people aged under 65. The committee cited insufficient data over its efficacy for older people. The European Medicines Agency is to decide on Friday whether to approve the vaccine for use across the EU. The UK has been using the AstraZeneca vaccine in its mass immunisation programme for weeks now, and public health officials say it is safe and provides high levels of protection . The German announcement comes as the EU is in dispute with leading manufacturers over a shortage of vaccines on the continent.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.